PEMETREXED HEMIPENTAHYDRATE for Lung adenocarcinoma stage iv: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where PEMETREXED HEMIPENTAHYDRATE was used for Lung adenocarcinoma stage iv.
Most Reported Side Effects for PEMETREXED HEMIPENTAHYDRATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 9 | 13.2% | 2 | 1 |
| Acquired gene mutation | 7 | 10.3% | 0 | 0 |
| Pulmonary embolism | 7 | 10.3% | 0 | 0 |
| Renal impairment | 7 | 10.3% | 0 | 4 |
| Off label use | 6 | 8.8% | 0 | 0 |
| Anaemia | 5 | 7.4% | 0 | 4 |
| Death | 5 | 7.4% | 5 | 1 |
| Diarrhoea | 5 | 7.4% | 0 | 5 |
Other Indications for PEMETREXED HEMIPENTAHYDRATE
Non-small cell lung cancer (20)
Non-small cell lung cancer metastatic (12)
Lung adenocarcinoma (10)
Lung neoplasm malignant (8)
Other Drugs Used for Lung adenocarcinoma stage iv
PEMBROLIZUMAB (1,644)
PEMETREXED (1,510)
CARBOPLATIN (1,138)
CISPLATIN (303)
OSIMERTINIB (278)
PACLITAXEL (223)
BEVACIZUMAB (213)
ERLOTINIB (203)
DOCETAXEL (188)
CRIZOTINIB (164)